Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
61
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| McErlane David | Group President, Biologics | 6 | $0 | $119.6K | 2024-12-18 |
| Ryan Michelle R | Director | 6 | $50.0K | $167.2K | 2024-12-18 |
| Hopson Ricky | VP, Chief Accounting Officer | 39 | $0 | $1.11M | 2024-12-18 |
| Barber Michael J | Director | 6 | $0 | $0 | 2024-12-18 |
| Barg Steven | Director | 4 | $0 | $0 | 2024-12-18 |
| Hatzfeld Michael | Chief Accounting Officer | 7 | $0 | $0 | 2024-12-18 |
| Okey Stephanie | Director | 4 | $0 | $0 | 2024-12-18 |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | 10 | $0 | $55.4K | 2024-12-18 |
| Gunther Scott | See Remarks | 66 | $0 | $1.81M | 2024-12-18 |
| Maselli Alessandro | See remarks | 64 | $0 | $2.27M | 2024-12-18 |
| Evoli Lisa | SVP, Chief HR Officer | 6 | $0 | $230.3K | 2024-12-18 |
| Gennadios Aristippos | See Remarks | 120 | $0 | $5.99M | 2024-12-18 |
| Masanovich Matti | SVP, Chief Financial Officer | 8 | $0 | $169.8K | 2024-12-18 |
| CARROLL J MARTIN | Director | 25 | $0 | $0 | 2024-12-18 |
| GREISCH JOHN J | Executive Chair | 15 | $1.54M | $0 | 2024-12-18 |
| LUCIER GREGORY T | Director | 21 | $312.9K | $2.81M | 2024-12-18 |
| MOREL DONALD E JR | Director | 14 | $1.17M | $0 | 2024-12-18 |
| DAMELIO FRANK A | Director | 4 | $0 | $0 | 2024-12-18 |
| CLASSON ROLF A | Director | 12 | $0 | $0 | 2024-12-18 |
| STAHL JACK L | Director | 12 | $0 | $0 | 2024-12-18 |
| Kreuzburg Christa | Director | 15 | $0 | $0 | 2024-01-25 |
| Balachandran Madhavan | Director | 8 | $0 | $0 | 2023-10-27 |
| Flynn Karen | Pres. Biologics & CCO | 13 | $0 | $577.0K | 2023-10-27 |
| Crane Rosemary A | Director | 7 | $0 | $0 | 2023-10-27 |
| Hunt Patricia | Pres. Consumer Health Div | 10 | $0 | $47.4K | 2023-10-16 |
| Lickfold Charles | SVP, CIO | 7 | $0 | $15.0K | 2023-08-24 |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | 10 | $0 | $160.1K | 2023-08-24 |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | 12 | $0 | $201.8K | 2023-08-24 |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | 44 | $0 | $1.72M | 2023-08-24 |
| Pravda Ricardo | SVP, Human Resources | 42 | $0 | $1.50M | 2023-08-24 |
| Arnold Jonathan | SVP, CCO & Div. Head BioP Del. | 65 | $0 | $3.30M | 2023-08-24 |
| Fasman Steven L | See Remarks | 105 | $0 | $10.72M | 2023-08-24 |
| Santiago Karen Murphy | VP & Chief Accounting Officer | 5 | $0 | $0 | 2023-08-01 |
| Zayas Ricardo | SVP, Operations, Biologics NA | 2 | $0 | $0 | 2023-08-01 |
| Boerman Manja | Pres. BioModalities Division | 4 | $0 | $452.0K | 2023-05-01 |
| Gargiulo Mario | SVP, Ops, Biologics Europe | 7 | $0 | $313.4K | 2023-05-01 |
| Zippelius Peter | Director | 13 | $0 | $973.14M | 2022-10-27 |
| Riley Michael A. | Pres. Bio Product Delivery Div | 3 | $0 | $411.9K | 2022-08-26 |
| Castellano Thomas P | SVP, Chief Financial Officer | 13 | $0 | $829.1K | 2022-08-25 |
| Schmidt Kay A | SVP, Technical Operations | 34 | $0 | $1.06M | 2022-08-25 |
| Chiminski John R | See Remarks | 142 | $0 | $96.05M | 2022-08-25 |
| Whitlow Ricci S | President, CSS | 9 | $0 | $109.7K | 2022-01-21 |
| Joseph Wetteny | See Remarks | 44 | $0 | $1.16M | 2021-02-16 |
| BUZY PETER L | President, Gene Therapy | 8 | $2.01M | $0 | 2020-04-09 |
| HEGWOOD PAUL W JR | President, CSS | 9 | $0 | $0 | 2019-08-22 |
| Littlejohns Barry | See Remarks | 52 | $0 | $2.82M | 2019-08-22 |
| Miyamoto Lance | See Remarks | 46 | $0 | $2.46M | 2019-03-07 |
| Downie William | See Remarks | 70 | $0 | $2.21M | 2019-02-15 |
| Roehrhoff Uwe | Director | 3 | $294.1K | $0 | 2017-11-21 |
| Dolan Christine | See Remarks | 14 | $0 | $87.7K | 2017-08-29 |
| QUELLA JAMES | Director | 3 | $0 | $0 | 2017-08-24 |
| WALSH MATTHEW M | See Remarks | 50 | $0 | $2.60M | 2017-08-24 |
| Johnson Sharon | See Remarks | 56 | $0 | $1.39M | 2017-04-25 |
| Blackstone Group L.P. | 10% Owner | 2 | $0 | $455.13M | 2016-09-09 |
| BOOTH MELVIN D | Director | 2 | $0 | $0 | 2016-08-24 |
| Leonard Stephen | See Remarks | 13 | $0 | $962.5K | 2016-07-26 |
| Blackstone Group Management L.L.C. | 10% Owner | 2 | $0 | $561.33M | 2016-06-09 |
| Houlton Scott | See Remarks | 27 | $0 | $897.3K | 2015-09-02 |
| Blackstone Healthcare Partners L.L.C. | 10% Owner | 1 | $0 | $0 | 2015-04-14 |
| Blackstone Holdings III GP Management L.L.C. | 10% Owner | 1 | $0 | $0 | 2015-03-09 |
| Kurt Nielsen | See Remarks | 8 | $0 | $1.35M | 2015-02-17 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Evoli Lisa | SVP, Chief HR Officer | D To issuer deriv | 2024-12-18 | 2024-12-18 | 14,225 | — | $0 | 0 | SEC↗ |
| GREISCH JOHN J | Executive Chair | D To issuer deriv | 2024-12-18 | 2024-12-18 | 127,096 | — | $0 | 0 | SEC↗ |
| Masanovich Matti | SVP, Chief Financial Officer | D To issuer deriv | 2024-12-18 | 2024-12-18 | 81,082 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | D To issuer deriv | 2024-12-18 | 2024-12-18 | 2,622 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | D To issuer deriv | 2024-12-18 | 2024-12-18 | 1,550 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | D To issuer deriv | 2024-12-18 | 2024-12-18 | 3,650 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | D To issuer deriv | 2024-12-18 | 2024-12-18 | 3,055 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | D To issuer deriv | 2024-12-18 | 2024-12-18 | 2,565 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | D To issuer deriv | 2024-12-18 | 2024-12-18 | 10,669 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | D To issuer deriv | 2024-12-18 | 2024-12-18 | 2,828 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer deriv | 2024-12-18 | 2024-12-18 | 11,093 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer deriv | 2024-12-18 | 2024-12-18 | 10,375 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer deriv | 2024-12-18 | 2024-12-18 | 13,735 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer deriv | 2024-12-18 | 2024-12-18 | 15,395 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer deriv | 2024-12-18 | 2024-12-18 | 15,568 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer deriv | 2024-12-18 | 2024-12-18 | 44,427 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer deriv | 2024-12-18 | 2024-12-18 | 103,360 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer deriv | 2024-12-18 | 2024-12-18 | 10,523 | — | $0 | 0 | SEC↗ |
| McErlane David | Group President, Biologics | D To issuer deriv | 2024-12-18 | 2024-12-18 | 14,740 | — | $0 | 0 | SEC↗ |
| Evoli Lisa | SVP, Chief HR Officer | D To issuer | 2024-12-18 | 2024-12-18 | 39,366 | — | $0 | 0 | SEC↗ |
| Evoli Lisa | SVP, Chief HR Officer | D To issuer | 2024-12-18 | 2024-12-18 | 12,032 | — | $0 | 0 | SEC↗ |
| Evoli Lisa | SVP, Chief HR Officer | A Award | 2024-12-18 | 2024-12-18 | 12,032 | — | $0 | 12,032 | SEC↗ |
| GREISCH JOHN J | Executive Chair | D To issuer | 2024-12-18 | 2024-12-18 | 33,530 | — | $0 | 0 | SEC↗ |
| GREISCH JOHN J | Executive Chair | A Award | 2024-12-18 | 2024-12-18 | 33,530 | — | $0 | 33,530 | SEC↗ |
| GREISCH JOHN J | Executive Chair | D To issuer | 2024-12-18 | 2024-12-18 | 34,000 | — | $0 | 0 | SEC↗ |
| GREISCH JOHN J | Executive Chair | D To issuer | 2024-12-18 | 2024-12-18 | 79,932 | — | $0 | 0 | SEC↗ |
| Masanovich Matti | SVP, Chief Financial Officer | D To issuer | 2024-12-18 | 2024-12-18 | 76,475 | — | $0 | 0 | SEC↗ |
| Masanovich Matti | SVP, Chief Financial Officer | A Award | 2024-12-18 | 2024-12-18 | 71,691 | — | $0 | 71,691 | SEC↗ |
| Masanovich Matti | SVP, Chief Financial Officer | D To issuer | 2024-12-18 | 2024-12-18 | 71,691 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | D To issuer | 2024-12-18 | 2024-12-18 | 29,974 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | D To issuer | 2024-12-18 | 2024-12-18 | 10,722 | — | $0 | 0 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | A Award | 2024-12-18 | 2024-12-18 | 10,722 | — | $0 | 10,722 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer | 2024-12-18 | 2024-12-18 | 113,224 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | D To issuer | 2024-12-18 | 2024-12-18 | 177,521 | — | $0 | 0 | SEC↗ |
| Maselli Alessandro | President & CEO | A Award | 2024-12-18 | 2024-12-18 | 113,224 | — | $0 | 113,224 | SEC↗ |
| Barber Michael J | Director | D To issuer | 2024-12-18 | 2024-12-18 | 18,052 | — | $0 | 0 | SEC↗ |
| Barg Steven | Director | D To issuer | 2024-12-18 | 2024-12-18 | 12,374 | — | $0 | 0 | SEC↗ |
| CARROLL J MARTIN | Director | D To issuer | 2024-12-18 | 2024-12-18 | 32,734 | — | $0 | 0 | SEC↗ |
| CLASSON ROLF A | Director | D To issuer | 2024-12-18 | 2024-12-18 | 47,984 | — | $0 | 0 | SEC↗ |
| DAMELIO FRANK A | Director | D To issuer | 2024-12-18 | 2024-12-18 | 12,635 | — | $0 | 0 | SEC↗ |
| LUCIER GREGORY T | Director | D To issuer | 2024-12-18 | 2024-12-18 | 36,914 | — | $0 | 0 | SEC↗ |
| MOREL DONALD E JR | Director | D To issuer | 2024-12-18 | 2024-12-18 | 70,118 | — | $0 | 0 | SEC↗ |
| Okey Stephanie | Director | D To issuer | 2024-12-18 | 2024-12-18 | 12,635 | — | $0 | 0 | SEC↗ |
| Ryan Michelle R | Director | D To issuer | 2024-12-18 | 2024-12-18 | 10,835 | — | $0 | 0 | SEC↗ |
| STAHL JACK L | Director | D To issuer | 2024-12-18 | 2024-12-18 | 47,984 | — | $0 | 0 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | D To issuer | 2024-12-18 | 2024-12-18 | 14,265 | — | $0 | 0 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | D To issuer | 2024-12-18 | 2024-12-18 | 23,967 | — | $0 | 0 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | A Award | 2024-12-18 | 2024-12-18 | 14,265 | — | $0 | 14,265 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | A Award | 2024-12-18 | 2024-12-18 | 12,938 | — | $0 | 12,938 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | D To issuer | 2024-12-18 | 2024-12-18 | 39,635 | — | $0 | 0 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | D To issuer | 2024-12-18 | 2024-12-18 | 12,938 | — | $0 | 0 | SEC↗ |
| Hatzfeld Michael | Chief Accounting Officer | A Award | 2024-12-18 | 2024-12-18 | 3,144 | — | $0 | 3,144 | SEC↗ |
| Hatzfeld Michael | Chief Accounting Officer | D To issuer | 2024-12-18 | 2024-12-18 | 13,532 | — | $0 | 0 | SEC↗ |
| Hatzfeld Michael | Chief Accounting Officer | D To issuer | 2024-12-18 | 2024-12-18 | 3,144 | — | $0 | 0 | SEC↗ |
| McErlane David | Group President, Biologics | D To issuer | 2024-12-18 | 2024-12-18 | 36,304 | — | $0 | 0 | SEC↗ |
| McErlane David | Group President, Biologics | D To issuer | 2024-12-18 | 2024-12-18 | 11,426 | — | $0 | 0 | SEC↗ |
| McErlane David | Group President, Biologics | A Award | 2024-12-18 | 2024-12-18 | 11,426 | — | $0 | 11,426 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | D To issuer | 2024-12-18 | 2024-12-18 | 113,724 | — | $0 | 0 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | A Award | 2024-12-18 | 2024-12-18 | 21,562 | — | $0 | 21,562 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | D To issuer | 2024-12-18 | 2024-12-18 | 21,562 | — | $0 | 0 | SEC↗ |
| Ryan Michelle R | Director | S Sale | 2024-11-11 | 2024-11-14 | 2,800 | $59.70 | $167.2K | 10,835 | SEC↗ |
| STAHL JACK L | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 47,984 | SEC↗ |
| CLASSON ROLF A | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 47,984 | SEC↗ |
| LUCIER GREGORY T | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 36,914 | SEC↗ |
| CARROLL J MARTIN | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 32,734 | SEC↗ |
| MOREL DONALD E JR | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 70,118 | SEC↗ |
| Barber Michael J | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 18,052 | SEC↗ |
| DAMELIO FRANK A | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 12,635 | SEC↗ |
| Okey Stephanie | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 12,635 | SEC↗ |
| Ryan Michelle R | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 13,635 | SEC↗ |
| Barg Steven | Director | A Award | 2024-10-30 | 2024-11-01 | 4,663 | — | $0 | 12,374 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | S Sale | 2024-10-18 | 2024-10-21 | 320 | $59.97 | $19.2K | 23,967 | SEC↗ |
| McErlane David | Group President, Biologics | S Sale | 2024-09-26 | 2024-09-27 | 1,994 | $59.97 | $119.6K | 36,304 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | S Sale | 2024-08-02 | 2024-08-05 | 1,169 | $59.55 | $69.6K | 113,724 | SEC↗ |
| Evoli Lisa | SVP, Chief HR Officer | S Sale | 2024-08-02 | 2024-08-05 | 3,859 | $59.67 | $230.3K | 39,366 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | S Sale | 2024-08-02 | 2024-08-05 | 608 | $59.58 | $36.2K | 24,287 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | S Sale | 2024-08-02 | 2024-08-05 | 666 | $59.55 | $39.7K | 39,635 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | S Sale | 2024-08-02 | 2024-08-05 | 662 | $59.56 | $39.4K | 29,974 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | S Sale | 2024-07-29 | 2024-07-30 | 349 | $58.70 | $20.5K | 114,893 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | S Sale | 2024-07-29 | 2024-07-30 | 283 | $58.69 | $16.6K | 40,301 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | S Sale | 2024-07-29 | 2024-07-30 | 206 | $58.67 | $12.1K | 30,636 | SEC↗ |
| Maselli Alessandro | President & CEO | S Sale | 2024-07-29 | 2024-07-30 | 9,088 | $58.76 | $534.0K | 177,521 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | A Award | 2024-07-26 | 2024-07-30 | 18,746 | — | $0 | 115,242 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | A Award | 2024-07-26 | 2024-07-30 | 11,078 | — | $0 | 40,584 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | A Award | 2024-07-26 | 2024-07-30 | 10,225 | — | $0 | 30,842 | SEC↗ |
| Maselli Alessandro | President & CEO | A Award | 2024-07-26 | 2024-07-30 | 98,671 | — | $0 | 186,609 | SEC↗ |
| Masanovich Matti | SVP, Chief Financial Officer | A Award | 2024-07-26 | 2024-07-30 | 42,604 | — | $0 | 76,475 | SEC↗ |
| Evoli Lisa | SVP, Chief HR Officer | A Award | 2024-07-26 | 2024-07-30 | 15,338 | — | $0 | 43,225 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | A Award | 2024-07-26 | 2024-07-30 | 17,042 | — | $0 | 24,895 | SEC↗ |
| McErlane David | Group President, Biologics | A Award | 2024-07-26 | 2024-07-30 | 18,746 | — | $0 | 38,298 | SEC↗ |
| Hatzfeld Michael | Chief Accounting Officer | A Award | 2024-07-26 | 2024-07-30 | 5,624 | — | $0 | 13,532 | SEC↗ |
| GREISCH JOHN J | Executive Chair | A Award | 2024-07-26 | 2024-07-30 | 63,736 | — | $0 | 79,932 | SEC↗ |
| Masanovich Matti | SVP, Chief Financial Officer | S Sale | 2024-07-08 | 2024-07-10 | 2,993 | $56.74 | $169.8K | 33,871 | SEC↗ |
| Hopson Ricky | Pres. BioProduct Delivery, C | S Sale | 2024-06-04 | 2024-06-05 | 1,401 | $54.26 | $76.0K | 20,617 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | S Sale | 2024-03-15 | 2024-03-19 | 387 | $56.20 | $21.7K | 29,506 | SEC↗ |
| Kreuzburg Christa | Director | F Tax w/h | 2024-01-25 | 2024-01-29 | 523 | $50.41 | $26.4K | 18,283 | SEC↗ |
| Hatzfeld Michael | Chief Accounting Officer | A Award deriv | 2024-01-16 | 2024-01-18 | 3,981 | — | $0 | 3,981 | SEC↗ |
| Hatzfeld Michael | Chief Accounting Officer | A Award | 2024-01-16 | 2024-01-18 | 1,837 | — | $0 | 1,837 | SEC↗ |
| Hatzfeld Michael | Chief Accounting Officer | A Award | 2024-01-16 | 2024-01-18 | 6,071 | — | $0 | 7,908 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | F Tax w/h | 2023-12-08 | 2023-12-12 | 256 | $37.18 | $9.5K | 22,018 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | A Award | 2023-12-08 | 2023-12-12 | 747 | — | $0 | 22,274 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | A Award | 2023-12-08 | 2023-12-12 | 1,023 | — | $0 | 30,143 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | F Tax w/h | 2023-12-08 | 2023-12-12 | 250 | $37.18 | $9.3K | 29,893 | SEC↗ |
| Maselli Alessandro | President & CEO | A Award | 2023-12-08 | 2023-12-12 | 3,761 | — | $0 | 89,862 | SEC↗ |
| Maselli Alessandro | President & CEO | F Tax w/h | 2023-12-08 | 2023-12-12 | 1,924 | $37.18 | $71.5K | 87,938 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | A Award | 2023-12-08 | 2023-12-12 | 1,505 | — | $0 | 96,863 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | F Tax w/h | 2023-12-08 | 2023-12-12 | 367 | $37.18 | $13.6K | 96,496 | SEC↗ |
| Okey Stephanie | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 7,972 | SEC↗ |
| STAHL JACK L | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 43,321 | SEC↗ |
| MOREL DONALD E JR | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 65,455 | SEC↗ |
| Ryan Michelle R | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 8,972 | SEC↗ |
| LUCIER GREGORY T | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 32,251 | SEC↗ |
| Kreuzburg Christa | Director | F Tax w/h | 2023-10-27 | 2023-10-31 | 1,245 | $39.32 | $49.0K | 18,806 | SEC↗ |
| Kreuzburg Christa | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 20,051 | SEC↗ |
| DAMELIO FRANK A | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 7,972 | SEC↗ |
| Flynn Karen | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 24,339 | SEC↗ |
| Crane Rosemary A | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 23,873 | SEC↗ |
| CLASSON ROLF A | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 43,321 | SEC↗ |
| CARROLL J MARTIN | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 28,071 | SEC↗ |
| Barber Michael J | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 13,389 | SEC↗ |
| Balachandran Madhavan | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 27,441 | SEC↗ |
| Barg Steven | Director | A Award | 2023-10-27 | 2023-10-31 | 6,993 | — | $0 | 7,711 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | A Award deriv | 2023-10-17 | 2023-10-19 | 5,902 | — | $0 | 5,902 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | A Award | 2023-10-17 | 2023-10-19 | 2,708 | — | $0 | 7,853 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | F Tax w/h | 2023-10-16 | 2023-10-18 | 22 | $46.52 | $1.0K | 11,267 | SEC↗ |
| Barg Steven | Director | A Award | 2023-09-10 | 2023-09-12 | 718 | — | $0 | 718 | SEC↗ |
| Ryan Michelle R | Director | P Buy | 2023-08-31 | 2023-09-05 | 1,000 | $49.98 | $50.0K | 1,979 | SEC↗ |
| GREISCH JOHN J | Executive Chair | A Award deriv | 2023-08-30 | 2023-09-01 | 127,096 | — | $0 | 127,096 | SEC↗ |
| GREISCH JOHN J | Executive Chair | P Buy | 2023-08-30 | 2023-09-01 | 21,000 | $50.24 | $1.06M | 34,000 | SEC↗ |
| DAMELIO FRANK A | Director | A Award | 2023-08-28 | 2023-08-30 | 979 | — | $0 | 979 | SEC↗ |
| Ryan Michelle R | Director | A Award | 2023-08-28 | 2023-08-30 | 979 | — | $0 | 979 | SEC↗ |
| Okey Stephanie | Director | A Award | 2023-08-28 | 2023-08-30 | 979 | — | $0 | 979 | SEC↗ |
| Arnold Jonathan | SVP, CCO & Div. Head BioP De | J Other | 2023-08-24 | 2023-12-12 | 87 | — | $0 | 55,896 | SEC↗ |
| Maselli Alessandro | President & CEO | J Other | 2023-08-24 | 2023-12-12 | 2,071 | — | $0 | 86,101 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | J Other | 2023-08-24 | 2023-12-12 | 269 | — | $0 | 29,120 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | J Other | 2023-08-24 | 2023-12-12 | 390 | — | $0 | 23,725 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | J Other | 2023-08-24 | 2023-12-12 | 396 | — | $0 | 95,358 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | J Other | 2023-08-24 | 2023-12-12 | 216 | — | $0 | 8,505 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | J Other | 2023-08-24 | 2023-12-12 | 817 | — | $0 | 72,380 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | J Other | 2023-08-24 | 2023-12-12 | 276 | — | $0 | 21,527 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | J Other | 2023-08-24 | 2023-12-12 | 147 | — | $0 | 7,412 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | J Other | 2023-08-24 | 2023-12-12 | 106 | — | $0 | 11,106 | SEC↗ |
| Lickfold Charles | SVP, CIO | J Other | 2023-08-24 | 2023-12-12 | 190 | — | $0 | 10,892 | SEC↗ |
| Pravda Ricardo | Chief Transformation Officer | J Other | 2023-08-24 | 2023-12-12 | 379 | — | $0 | 29,522 | SEC↗ |
| Pravda Ricardo | Chief Transformation Officer | S Sale | 2023-08-24 | 2023-08-25 | 379 | $44.47 | $16.9K | 30,224 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | S Sale | 2023-08-24 | 2023-08-25 | 106 | $44.77 | $4.7K | 11,289 | SEC↗ |
| Lickfold Charles | SVP, CIO | S Sale | 2023-08-24 | 2023-08-25 | 190 | $44.72 | $8.5K | 11,339 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | S Sale | 2023-08-24 | 2023-08-25 | 147 | $44.72 | $6.6K | 7,533 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | S Sale | 2023-08-24 | 2023-08-25 | 276 | $44.56 | $12.3K | 22,040 | SEC↗ |
| Arnold Jonathan | SVP, CCO & Div. Head BioP De | S Sale | 2023-08-24 | 2023-08-25 | 87 | $44.87 | $3.9K | 57,399 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | S Sale | 2023-08-24 | 2023-08-25 | 216 | $44.71 | $9.7K | 8,746 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | S Sale | 2023-08-24 | 2023-08-25 | 817 | $44.65 | $36.5K | 73,789 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | S Sale | 2023-08-24 | 2023-08-25 | 396 | $44.49 | $17.6K | 96,552 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | S Sale | 2023-08-24 | 2023-08-25 | 390 | $44.50 | $17.4K | 24,449 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | S Sale | 2023-08-24 | 2023-08-25 | 269 | $44.57 | $12.0K | 29,932 | SEC↗ |
| Maselli Alessandro | President & CEO | S Sale | 2023-08-24 | 2023-08-25 | 1,970 | $44.51 | $87.7K | 88,105 | SEC↗ |
| Maselli Alessandro | President & CEO | S Sale | 2023-08-24 | 2023-08-25 | 101 | $45.15 | $4.6K | 88,004 | SEC↗ |
| Arnold Jonathan | SVP, CCO & Div. Head BioP De | J Other | 2023-08-23 | 2023-12-12 | 1,590 | — | $0 | 55,809 | SEC↗ |
| Maselli Alessandro | President & CEO | J Other | 2023-08-23 | 2023-12-12 | 3,974 | — | $0 | 84,030 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | J Other | 2023-08-23 | 2023-12-12 | 1,081 | — | $0 | 28,851 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | J Other | 2023-08-23 | 2023-12-12 | 1,114 | — | $0 | 23,335 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | J Other | 2023-08-23 | 2023-12-12 | 1,590 | — | $0 | 94,962 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | J Other | 2023-08-23 | 2023-12-12 | 457 | — | $0 | 8,289 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | J Other | 2023-08-23 | 2023-12-12 | 2,226 | — | $0 | 71,563 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | J Other | 2023-08-23 | 2023-12-12 | 789 | — | $0 | 21,251 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | J Other | 2023-08-23 | 2023-12-12 | 268 | — | $0 | 7,265 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | J Other | 2023-08-23 | 2023-12-12 | 289 | — | $0 | 11,000 | SEC↗ |
| Lickfold Charles | SVP, CIO | J Other | 2023-08-23 | 2023-12-12 | 637 | — | $0 | 10,702 | SEC↗ |
| Pravda Ricardo | Chief Transformation Officer | J Other | 2023-08-23 | 2023-12-12 | 1,081 | — | $0 | 29,143 | SEC↗ |
| Pravda Ricardo | Chief Transformation Officer | A Award | 2023-08-23 | 2023-08-25 | 1,081 | — | $0 | 30,603 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | A Award | 2023-08-23 | 2023-08-25 | 289 | — | $0 | 11,395 | SEC↗ |
| Lickfold Charles | SVP, CIO | A Award | 2023-08-23 | 2023-08-25 | 637 | — | $0 | 11,529 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | A Award | 2023-08-23 | 2023-08-25 | 268 | — | $0 | 7,680 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | A Award | 2023-08-23 | 2023-08-25 | 789 | — | $0 | 21,836 | SEC↗ |
| Arnold Jonathan | SVP, CCO & Div. Head BioP De | A Award | 2023-08-23 | 2023-08-25 | 1,590 | — | $0 | 57,486 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | A Award | 2023-08-23 | 2023-08-25 | 457 | — | $0 | 8,962 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | A Award | 2023-08-23 | 2023-08-25 | 2,226 | — | $0 | 74,327 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | A Award | 2023-08-23 | 2023-08-25 | 1,590 | — | $0 | 96,948 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | A Award | 2023-08-23 | 2023-08-25 | 1,114 | — | $0 | 24,839 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | A Award | 2023-08-23 | 2023-08-25 | 1,081 | — | $0 | 30,201 | SEC↗ |
| Maselli Alessandro | President & CEO | A Award | 2023-08-23 | 2023-08-25 | 3,974 | — | $0 | 90,075 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | A Award deriv | 2023-08-01 | 2023-08-03 | 26,473 | — | $0 | 26,473 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | A Award deriv | 2023-08-01 | 2023-08-03 | 8,693 | — | $0 | 8,693 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | A Award deriv | 2023-08-01 | 2023-08-03 | 19,756 | — | $0 | 19,756 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | A Award deriv | 2023-08-01 | 2023-08-03 | 13,830 | — | $0 | 13,830 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | A Award deriv | 2023-08-01 | 2023-08-03 | 11,854 | — | $0 | 11,854 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | A Award deriv | 2023-08-01 | 2023-08-03 | 5,137 | — | $0 | 5,137 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | A Award deriv | 2023-08-01 | 2023-08-03 | 10,669 | — | $0 | 10,669 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | A Award deriv | 2023-08-01 | 2023-08-03 | 4,347 | — | $0 | 4,347 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | A Award deriv | 2023-08-01 | 2023-08-03 | 11,459 | — | $0 | 11,459 | SEC↗ |
| Lickfold Charles | SVP, CIO | A Award deriv | 2023-08-01 | 2023-08-03 | 11,854 | — | $0 | 11,854 | SEC↗ |
| Zayas Ricardo | SVP, Operations, Biologics N | A Award deriv | 2023-08-01 | 2023-08-03 | 9,878 | — | $0 | 9,878 | SEC↗ |
| Santiago Karen Murphy | VP & Chief Accounting Office | A Award deriv | 2023-08-01 | 2023-08-03 | 5,216 | — | $0 | 5,216 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | A Award | 2023-08-01 | 2023-08-03 | 11,885 | — | $0 | 72,101 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | S Sale | 2023-08-01 | 2023-08-03 | 1,113 | $46.72 | $52.0K | 60,740 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | S Sale | 2023-08-01 | 2023-08-03 | 524 | $47.76 | $25.0K | 60,216 | SEC↗ |
| Arnold Jonathan | SVP, CCO & Div. Head BioP De | S Sale | 2023-08-01 | 2023-08-03 | 62 | $47.80 | $3.0K | 55,896 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | S Sale | 2023-08-01 | 2023-08-03 | 383 | $47.77 | $18.3K | 4,602 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | A Award | 2023-08-01 | 2023-08-03 | 3,903 | — | $0 | 8,505 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | S Sale | 2023-08-01 | 2023-08-03 | 61 | $46.58 | $2.8K | 86,708 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | S Sale | 2023-08-01 | 2023-08-03 | 220 | $47.87 | $10.5K | 86,488 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | A Award | 2023-08-01 | 2023-08-03 | 8,870 | — | $0 | 95,358 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | S Sale | 2023-08-01 | 2023-08-03 | 35 | $46.64 | $1.6K | 17,757 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | A Award | 2023-08-01 | 2023-08-03 | 6,209 | — | $0 | 23,725 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | S Sale | 2023-08-01 | 2023-08-03 | 241 | $47.88 | $11.5K | 17,516 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | A Award | 2023-08-01 | 2023-08-03 | 5,322 | — | $0 | 29,120 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | S Sale | 2023-08-01 | 2023-08-03 | 190 | $47.90 | $9.1K | 23,798 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | S Sale | 2023-08-01 | 2023-08-03 | 258 | $47.97 | $12.4K | 5,106 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | A Award | 2023-08-01 | 2023-08-03 | 2,306 | — | $0 | 7,412 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | A Award | 2023-08-01 | 2023-08-03 | 4,790 | — | $0 | 21,047 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | S Sale | 2023-08-01 | 2023-08-03 | 195 | $47.86 | $9.3K | 16,257 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | A Award | 2023-08-01 | 2023-08-03 | 1,952 | — | $0 | 11,106 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | S Sale | 2023-08-01 | 2023-08-03 | 161 | $47.95 | $7.7K | 9,154 | SEC↗ |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | A Award | 2023-08-01 | 2023-08-03 | 5,145 | — | $0 | 5,145 | SEC↗ |
| Lickfold Charles | SVP, CIO | S Sale | 2023-08-01 | 2023-08-03 | 135 | $47.90 | $6.5K | 5,570 | SEC↗ |
| Lickfold Charles | SVP, CIO | A Award | 2023-08-01 | 2023-08-03 | 5,322 | — | $0 | 10,892 | SEC↗ |
| Maselli Alessandro | President & CEO | S Sale | 2023-08-01 | 2023-08-03 | 879 | $46.71 | $41.1K | 86,707 | SEC↗ |
| Maselli Alessandro | President & CEO | S Sale | 2023-08-01 | 2023-08-03 | 606 | $47.75 | $28.9K | 86,101 | SEC↗ |
| Pravda Ricardo | Chief Transformation Officer | S Sale | 2023-08-01 | 2023-08-03 | 47 | $46.50 | $2.2K | 19,961 | SEC↗ |
| Pravda Ricardo | Chief Transformation Officer | S Sale | 2023-08-01 | 2023-08-03 | 222 | $47.78 | $10.6K | 19,739 | SEC↗ |
| Pravda Ricardo | Chief Transformation Officer | A Award | 2023-08-01 | 2023-08-03 | 9,783 | — | $0 | 29,522 | SEC↗ |
| Zayas Ricardo | SVP, Operations, Biologics N | A Award | 2023-08-01 | 2023-08-03 | 4,435 | — | $0 | 6,223 | SEC↗ |
| Santiago Karen Murphy | VP & Chief Accounting Office | A Award | 2023-08-01 | 2023-08-03 | 2,342 | — | $0 | 4,763 | SEC↗ |
| Maselli Alessandro | President & CEO | A Award deriv | 2023-07-26 | 2023-07-28 | 103,360 | — | $0 | 103,360 | SEC↗ |
| Maselli Alessandro | President & CEO | A Award | 2023-07-26 | 2023-07-28 | 46,396 | — | $0 | 87,586 | SEC↗ |
| Masanovich Matti | SVP, Chief Financial Officer | A Award deriv | 2023-07-05 | 2023-07-07 | 81,082 | — | $0 | 81,082 | SEC↗ |
| Masanovich Matti | SVP, Chief Financial Officer | A Award | 2023-07-05 | 2023-07-07 | 36,864 | — | $0 | 36,864 | SEC↗ |
| CARROLL J MARTIN | Director | A Award | 2023-07-01 | 2023-07-07 | 555 | — | $0 | 21,078 | SEC↗ |
| Gargiulo Mario | SVP, Ops, Biologics Europe | S Sale | 2023-05-01 | 2023-05-03 | 678 | $49.86 | $33.8K | 5,676 | SEC↗ |
| Boerman Manja | Pres. BioModalities Division | S Sale | 2023-05-01 | 2023-05-03 | 1,446 | $49.86 | $72.1K | 14,414 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | S Sale | 2023-01-23 | 2023-01-25 | 643 | $49.36 | $31.7K | 16,452 | SEC↗ |
| Boerman Manja | Pres. BioModalities Division | S Sale | 2022-12-05 | 2022-12-07 | 780 | $51.70 | $40.3K | 15,860 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | S Sale | 2022-10-31 | 2022-11-02 | 2,451 | $65.83 | $161.3K | 17,792 | SEC↗ |
| Balachandran Madhavan | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 20,448 | SEC↗ |
| Barber Michael J | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 6,396 | SEC↗ |
| CARROLL J MARTIN | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 20,523 | SEC↗ |
| CLASSON ROLF A | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 36,328 | SEC↗ |
| Crane Rosemary A | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 16,880 | SEC↗ |
| Flynn Karen | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 17,346 | SEC↗ |
| GREISCH JOHN J | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 16,880 | SEC↗ |
| Kreuzburg Christa | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 13,479 | SEC↗ |
| Kreuzburg Christa | Director | F Tax w/h | 2022-10-27 | 2022-10-31 | 421 | $66.27 | $27.9K | 13,058 | SEC↗ |
| LUCIER GREGORY T | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 25,258 | SEC↗ |
| MOREL DONALD E JR | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 58,462 | SEC↗ |
| STAHL JACK L | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 36,328 | SEC↗ |
| Zippelius Peter | Director | A Award | 2022-10-27 | 2022-10-31 | 4,149 | — | $0 | 11,979 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | S Sale | 2022-10-10 | 2022-10-12 | 930 | $77.46 | $72.0K | 5,364 | SEC↗ |
| Santiago Karen Murphy | VP & Chief Accounting Office | A Award deriv | 2022-09-19 | 2022-09-21 | 3,030 | — | $0 | 3,030 | SEC↗ |
| Santiago Karen Murphy | VP & Chief Accounting Office | A Award | 2022-09-19 | 2022-09-21 | 1,681 | — | $0 | 2,421 | SEC↗ |
| Santiago Karen Murphy | VP & Chief Accounting Office | A Award | 2022-09-19 | 2022-09-21 | 740 | — | $0 | 740 | SEC↗ |
| Flynn Karen | Director | A Award | 2022-09-15 | 2022-09-19 | 245 | — | $0 | 13,197 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | S Sale | 2022-08-31 | 2022-09-02 | 2,216 | $89.59 | $198.5K | 17,095 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | S Sale | 2022-08-26 | 2022-08-30 | 1,639 | $104.07 | $170.6K | 23,988 | SEC↗ |
| Riley Michael A. | Pres. Bio Product Delivery D | S Sale | 2022-08-26 | 2022-08-30 | 2,491 | $104.07 | $259.2K | 6,592 | SEC↗ |
| Arnold Jonathan | SVP & Chief Commercial Ofcr | S Sale | 2022-08-25 | 2022-08-26 | 384 | $103.04 | $39.6K | 55,958 | SEC↗ |
| Boerman Manja | Pres. BioModalities Division | S Sale | 2022-08-25 | 2022-08-26 | 3,296 | $103.04 | $339.6K | 16,640 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | S Sale | 2022-08-25 | 2022-08-26 | 1,033 | $103.04 | $106.4K | 4,985 | SEC↗ |
| Castellano Thomas P | SVP, Chief Financial Officer | S Sale | 2022-08-25 | 2022-08-26 | 1,414 | $103.04 | $145.7K | 20,099 | SEC↗ |
| Chiminski John R | Executive Chair | S Sale | 2022-08-25 | 2022-08-26 | 38,934 | $103.04 | $4.01M | 229,888 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | S Sale | 2022-08-25 | 2022-08-26 | 4,811 | $103.04 | $495.7K | 61,853 | SEC↗ |
| Gargiulo Mario | SVP Global Ops Biologics | S Sale | 2022-08-25 | 2022-08-26 | 1,586 | $103.04 | $163.4K | 6,354 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | S Sale | 2022-08-25 | 2022-08-26 | 1,645 | $103.04 | $169.5K | 86,769 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | S Sale | 2022-08-25 | 2022-08-26 | 1,670 | $103.04 | $172.1K | 20,243 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | S Sale | 2022-08-25 | 2022-08-26 | 1,840 | $103.04 | $189.6K | 25,627 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | S Sale | 2022-08-25 | 2022-08-26 | 671 | $103.04 | $69.1K | 6,294 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | S Sale | 2022-08-25 | 2022-08-26 | 1,517 | $103.04 | $156.3K | 19,311 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | S Sale | 2022-08-25 | 2022-08-26 | 339 | $103.04 | $34.9K | 9,315 | SEC↗ |
| Maselli Alessandro | President & CEO | S Sale | 2022-08-25 | 2022-08-26 | 4,646 | $103.04 | $478.7K | 41,190 | SEC↗ |
| Pravda Ricardo | SVP & Chief HR Officer | S Sale | 2022-08-25 | 2022-08-26 | 1,747 | $103.04 | $180.0K | 20,008 | SEC↗ |
| Riley Michael A. | Pres. Bio Product Delivery D | S Sale | 2022-08-25 | 2022-08-26 | 1,482 | $103.04 | $152.7K | 9,083 | SEC↗ |
| Schmidt Kay A | SVP, Enterprise Functions | S Sale | 2022-08-25 | 2022-08-26 | 1,321 | $103.04 | $136.1K | 17,388 | SEC↗ |
| Arnold Jonathan | SVP & Chief Commercial Ofcr | A Award | 2022-08-24 | 2022-08-26 | 6,621 | — | $0 | 56,342 | SEC↗ |
| Boerman Manja | Pres. BioModalities Division | A Award | 2022-08-24 | 2022-08-26 | 6,676 | — | $0 | 19,936 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | A Award | 2022-08-24 | 2022-08-26 | 2,232 | — | $0 | 6,018 | SEC↗ |
| Castellano Thomas P | SVP, Chief Financial Officer | A Award | 2022-08-24 | 2022-08-26 | 4,139 | — | $0 | 21,513 | SEC↗ |
| Chiminski John R | Executive Chair | A Award | 2022-08-24 | 2022-08-26 | 99,275 | — | $0 | 268,822 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | A Award | 2022-08-24 | 2022-08-26 | 10,155 | — | $0 | 66,664 | SEC↗ |
| Gargiulo Mario | SVP Global Ops Biologics | A Award | 2022-08-24 | 2022-08-26 | 3,432 | — | $0 | 7,940 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | A Award | 2022-08-24 | 2022-08-26 | 6,771 | — | $0 | 88,414 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | A Award | 2022-08-24 | 2022-08-26 | 4,890 | — | $0 | 21,913 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | A Award | 2022-08-24 | 2022-08-26 | 5,117 | — | $0 | 27,467 | SEC↗ |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery D | A Award | 2022-08-24 | 2022-08-26 | 1,253 | — | $0 | 6,965 | SEC↗ |
| Hopson Ricky | Pres. Clinical Dev Supply Di | A Award | 2022-08-24 | 2022-08-26 | 3,733 | — | $0 | 20,828 | SEC↗ |
| Hunt Patricia | Pres. Consumer Health Div | A Award | 2022-08-24 | 2022-08-26 | 949 | — | $0 | 9,654 | SEC↗ |
| Maselli Alessandro | President & CEO | A Award | 2022-08-24 | 2022-08-26 | 10,532 | — | $0 | 45,836 | SEC↗ |
| Pravda Ricardo | SVP & Chief HR Officer | A Award | 2022-08-24 | 2022-08-26 | 5,117 | — | $0 | 21,755 | SEC↗ |
| Riley Michael A. | Pres. Bio Product Delivery D | A Award | 2022-08-24 | 2022-08-26 | 3,973 | — | $0 | 10,565 | SEC↗ |
| Schmidt Kay A | SVP, Enterprise Functions | A Award | 2022-08-24 | 2022-08-26 | 4,139 | — | $0 | 18,709 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | S Sale | 2022-07-27 | 2022-07-28 | 388 | $107.67 | $41.8K | 17,023 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | S Sale | 2022-07-27 | 2022-07-28 | 394 | $107.67 | $42.4K | 22,350 | SEC↗ |
| Hopson Ricky | Pres, Clinical Dev & Supply | S Sale | 2022-07-27 | 2022-07-28 | 591 | $107.67 | $63.6K | 17,095 | SEC↗ |
| Arnold Jonathan | SVP & Chief Commercial Ofcr | A Award deriv | 2022-07-26 | 2022-07-28 | 4,443 | — | $0 | 4,443 | SEC↗ |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlt | A Award deriv | 2022-07-26 | 2022-07-28 | 3,635 | — | $0 | 3,635 | SEC↗ |
| Castellano Thomas P | SVP, Chief Financial Officer | A Award deriv | 2022-07-26 | 2022-07-28 | 10,097 | — | $0 | 10,097 | SEC↗ |
| Fasman Steven L | EVP & Chief Admin Officer | A Award deriv | 2022-07-26 | 2022-07-28 | 12,117 | — | $0 | 12,117 | SEC↗ |
| Gargiulo Mario | SVP Global Ops Biologics | A Award deriv | 2022-07-26 | 2022-07-28 | 3,635 | — | $0 | 3,635 | SEC↗ |
| Gennadios Aristippos | Group Pres. Pharma & Consume | A Award deriv | 2022-07-26 | 2022-07-28 | 8,078 | — | $0 | 8,078 | SEC↗ |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | A Award deriv | 2022-07-26 | 2022-07-28 | 5,655 | — | $0 | 5,655 | SEC↗ |
| Gunther Scott | SVP, Quality & Reg. Affairs | A Award deriv | 2022-07-26 | 2022-07-28 | 4,847 | — | $0 | 4,847 | SEC↗ |
| Hopson Ricky | Pres, Clinical Dev & Supply | A Award deriv | 2022-07-26 | 2022-07-28 | 2,828 | — | $0 | 2,828 | SEC↗ |